Department of Obstetrics and Gynaecology, University of Cambridge

02/06/2026

Many congratulations to Professor Ashley Moffett, who has been elected a Fellow of the Royal Society (FRS), one of the highest honours in science. Ashley is Emeritus Professor of Reproductive Immunology in the Department of Pathology at the University of Cambridge.

https://royalsociety.org/people/ashley-moffett-10086/

13/05/2026

We talked all UTERINE FIBROIDS yesterday at Homerton College: patient awareness and empowerment, pathways to improve clinical practice, and the legislative changes needed for better patient care.

08/05/2026

ONLINE STREAMING AVAILABLE - “Breaking the Silence about Uterine Fibroids: A Pathway to Legislative Change” on May 12th at 12.30-7pm (UK time).

Info and registration here:
https://www.homerton.cam.ac.uk/events/breaking-silence-about-uterine-fibroids-pathway-legislative-change

07/05/2026

Earlier this week, the Crime and Policing bill received Royal Assent to put an end to prosecutions for women seeking abortions in England and Wales, and pardon those who have had an abortion in the past.

We believe in a woman's right to choose.

Earlier this week, the Crime and Policing bill received Royal Assent to put an end to prosecutions for women seeking abortions in England and Wales, and pardon those who have had an abortion in the past.

Like nearly 90% of the country, Wellbeing of Women believe in a woman's right to choose. Abortion is healthcare, and no woman should ever face the threat of jail for seeking to end her own pregnancy.

We'll continue to stand with The British Pregnancy Advisory Service (Bpas) and other organisations calling for the reform of abortion care in the UK.

06/05/2026

Exciting line-up of speakers for our symposium “Breaking the Silence about Uterine Fibroids: A Pathway to Legislative Change” on May 12th.

Follow this link to register and join the conversation:
https://www.homerton.cam.ac.uk/events/breaking-silence-about-uterine-fibroids-pathway-legislative-change

06/05/2026

A few days left to register for "Breaking the Silence about Uterine Fibroids: A Pathway to Legislative Change" !!! 🗓 Join us at Homerton College , Cambridge, UK on May 12th.
🔗 Register here to secure your spot: https://www.homerton.cam.ac.uk/events/breaking-silence-about-uterine-fibroids-pathway-legislative-change
We are very proud and excited to be collaborating with Sateria Venable, Founder and CEO of the Fibroid Foundation on our mission to change fibroid policy in the UK and abroad.

🫂 Organized by FibroidsFREE in partnership with the Cambridge University Department of Obstetrics and Gynaecology, FIbroid Foundation, APPG for Black Health and CAHN UK.

Breaking the Silence about Uterine Fibroids: A Pathway to Legislative Change Register Here 12:30, 12 May 2026 - 19:00, 12 May 2026 Homerton College, Mary Allen Building, Hills Road, Cambridge CB2 8PH We are excited to invite you to our forthcoming symposium, “Breaking the Silence about Uterine Fib...

05/05/2026

Celebrating our The Rosie Hospital midwives today! 🥳❤️

28/01/2026

24/01/2026

”If we could better identify which children are going to need help to meet their potential earlier on then there are support interventions that can be put in place when they are very young to get them to a place where they're ready to learn by the time they go to school.”
Professor Catherine Aiken, honorary consultant in maternal and fetal medicine at CUH and Chief Investigator for the BLOOMS study

👶💛 Finding neonatal intensive care babies who could benefit from extra support after leaving the hospital.

Children admitted to a NICU as newborns are more than twice as likely to struggle with their school readiness assessment at age five and these early hurdles can affect them well into adulthood.

A new study at the Rosie and two other hospitals in the region aims to understand which children may face challenges and explore ways to better support them and their families. It's led by University of Cambridge

Read more: https://orlo.uk/mVWQ7

23/01/2026

Innovative tools to predict risks in pregnancy

Medicines360 has acquired global licensing rights to new technologies designed by Cambridge researchers to predict the risk of pregnancy complications responsible for 50% of stillbirths. The newly licensed technologies were discovered and funded through Wellcome Leap’s In Utero program, which aims to measure, model and predict gestational development, with a primary focus to reduce stillbirth rates by half.

Biomarker prediction of pregnancy complications used statistical and machine learning methods and was performed by Dr Ruoyu Miao, co-supervised by Dr Sung Sam Gong and Prof Ulla Sovio. Principal Investigator Prof Gordon Smith and Co-Principal Investigators Prof Steve Charnock-Jones and Prof Paul Kirk were in San Francisco during the JP Morgan Healthcare Conference week for events hosted by Medicines360 and Wellcome Leap to discuss the new technologies. Prof Smith said: “The current approach to assessing stillbirth risk has not changed in 50 years. Our technologies, discovered using exceptionally robust clinical data, can provide clinicians with comprehensive risk stratification at every stage of pregnancy. Ultimately, we believe this approach will save the lives of mothers and babies.”

Medicines360 introduces cutting-edge pregnancy risk assessment tools for better identification of maternal health risks during pregnancy.